Method for generating nonpathogenic infectious pancreatic...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S204100, C424S205100, C435S235100, C435S236000, C435S320100, C435S325000, C435S472000, C536S023720

Reexamination Certificate

active

06274147

ABSTRACT:

BACKGROUND OF THE INVENTION
Aquatic Birnaviruses such as infectious pancreatic necrosis virus (IPNV) are the causal agent of a highly contagious and destructive disease of juvenile Rainbow and Brook trout, and Atlantic salmon (Wolf, K. 1988, Fish viruses and fish viral diseases. Canstock Publishing Associates, Cornell University Press, Ithaca and London.). Highly virulent strains of IPNV can cause greater than 90% mortality in hatchery stocks less than four months old and survivors of infection can remain lifelong asymptomatic carriers, and serve as reservoirs of infection (McAllister, P. E., W. J. Owens, and T. M. Ruppenthal. 1987, Detection of infectious pancreatic necrosis virus in pelleted cell and particulate components from ovarian fluid of Brook trout (
Salvilimus fontindis
). Dis. Aquat. Org. 2:235-237). In survivors of an IPNV epizootic, the virus persists and can cause severe growth retardation in individual fish exhibiting virus persistence (McKnight and Roberts; Br. Ven. J. 132:76-86, 1976). In smolts, the virus produces considerable necrosis or inflammation of the pancreas. The virus is capable of infecting a number of different hosts and has a worldwide presence (Pilcher and Fryer.
Crit. Rev. Microbial
. 7:287-364, 1980).
IPNV belongs to a group of viruses called Birnaviridae which includes other bisegmented RNA viruses such as infectious bursal disease virus (chickens), tellina virus and oyster virus (bivalve mollusks) and drosophila X virus (fruit fly). These viruses all contain high molecular weight (MW) double-stranded RNA genomes. IPNV belongs to the Aquabirnavirus genus (Dobos, P. 1995, The molecular biology of infectious pancreatic necrosis virus (IPNV). Ann. Rev. Fish Dis. 5:24-54). Aquatic Birnaviruses infect marine and fresh water organisms such as fish, shrimp and other crustaceans, oysters and other mollusks.
IPNV in a brook trout hatchery was first reported in 1941(McGonigle
Trans. Am. Fish Soc
. 70,297, 1941). In 1960, the viral nature of the disease was confirmed (Wolf et al.,
Proc. Soc. Exp. Biol. Med
. 104:105-110,1960). Since that time there have been isolations of the virus in a variety of fish species throughout the world, including various trout and salmon species, carp, perch, pike, eels and char, as well as mollusks and crustaceans. Acute disease has been reported primarily in a limited number of salmonid species, such as a trout and salmon.
Young fish (two-to four-month old) appear to be the most susceptible to IPNV infection, resulting in high mortality (Wolf et al. U.S. Dept. Int. Bur. Sport Fish and Wildlife, Fish Disease Leaflet 1:14, 1966; Frantsi and Savan.
J. Wildlife Dis
. 7:249-255, 1971). In trout, IPNV usually attacks young fry about five to six weeks after their first feeding. The affected fish are darker than usual, have slightly bulging eyes and often have swollen bellies. At the beginning of an outbreak, large numbers of slow, dark fry are seen up against water outflows, and fish are seen “shivering” near the surface. The shivering results from a characteristic symptom of the disease, a violent whirling form of swimming in which the fish rotate about their long axis. If the affected fish are examined, a characteristic white mucus is seen in the stomach. The pancreas appears to be the primary target organ for the virus, with the pancreatic fat cells or Islets of Langerhans being unaffected (McKnight and Roberts,
Br. Vot. J
. 132:76-86, 1976). The only organ besides the pancreas where viral lesions are consistently found is the intestine.
After an IPNV outbreak, the surviving fish generally become carriers of the virus. Trout that are carriers of the virus are a serious problem for the aqua-culture industry because the only control method currently available for eliminating the virus in carrier fish is destruction of these fish. Several factors, including age, species and water temperature, appear to influence the severity of infection and the subsequent establishment of the carrier state. Surviving carriers shed IPNV for the remainder of their lifetime (Billi and Wolf,
J. Fish. Res. Bd. Can
. 26:1459-1465, 1969; Yamamoto,
Can. J. Micro
. 21:1343-1347, 1975; Reno et al.,
J. Fish. Res. Bd. Can
. 33:1451-1456, 1978). Therefore, IPNV is a pathogen of major economic importance to the aquaculture industry.
In view of the great deal of interest in developing a vaccine for IPNV a variety of approaches have been tried. One approach is the use of killed virus as vaccines. For example, if formalin-inactivated virus is injected intraperitoneally into four week post-hatch fry, the fish becomes immunized (Dorson,
J. Virol
21:242-258, 1977). However, neither immersion of the fish into a liquid suspension of killed virus nor oral administration thereof was effective. Thus, the main problem with using killed virus is the lack of a practical method for administration of the vaccine as injection is impractical for large numbers of immature fish. Some investigators have suggested that the uptake of viral antigen by immersion might be improved if the virus was disrupted into smaller, sub-viral components, but viral disruption methods have resulted in loss of antigenicity (Hill and Way, “Serological Classification of Fish and Shellfish Birnaviruses,” Abstract, First International Conference of the European Association of Pathology, Plymouth, England, 1983).
The use of attenuated viral strains has also been tried (Dorson, Abstract, International Conference on IPNV, Taloires, France, 1982). However, the earlier attenuated strains either fail to infect the fish or fail to induce protection. Strains with low virulence have been tested as vaccines for more virulent strains, but mortality from the vaccinating strain was either too high or protection was only moderate (Hill et al., “Studies of the Immunization of Trout Against IPN,” in
Fish Diseases
, Third COPRAQ Session (W. Ahne, ed.), N.Y., pp. 29-36, 1980).
There are two distinct serogroups of IPNV, designated as serogroup A and B. Serogroup A contains 9 serotypes, whereas serogroup B contains a single serotype (Hill, B. J., and K. Way. 1995, Serological classification of infectious pancreatic necrosis (IPN) virus and other aquatic birnaviruses. Ann. Rev. Fish Dis. 5:55-77).
The IPNV genome consists of two segments of double-stranded RNA that are surrounded by a single-shelled icosahedral capsid of 60 nm diameter (Dobos, P. 1976. Size and structure of the genome of infectious pancreatic necrosis virus. Nucl. Acids Res. 3:1903-1919). The larger of the two genomic segments, segment A (3097 bp), encodes a 106-kDa polyprotein (NH2-pVP2-NS protease-VP3-COOH) which is cotranslationally cleaved by the viral protease to generate mature VP2 and VP3 capsid proteins (Dobos, P. 1977. Virus-specific protein synthesis in cells inflicted by infectious pancreatic necrosis virus. J. Virol. 21:242-258; Duncan, R., E. Nagy, P. J. Krell, and P. Dobos. 1987, Synthesis of the infectious pancreatic necrosis virus polyprotein, detection of a virus-encoded protease, and fine structure mapping of genome segment A coding regions, J. Virol. 61:3655-3664). Segment A also encodes a 15-17 kDa arginine-rich nonstructural protein (NS) from a small open reading frame (ORF) which precedes and partially overlaps the major polyprotein ORF. Although this protein is not present in the virion, it is detected in IPNV-infected cells (Magyar, G., and P. Dobos. 1994 Evidence for the detection of the infectious pancreatic necrosis virus polyprotein and the 15-17 kDa polypeptide in infected cells and of the NS protease in purified virus. Virology 204:580-589). The genomic segment B (2784 bp) encodes VP1, a 94-kDa minor internal protein, which is the virion-associated RNA-dependent RNA polymerase (Dobos, P. 1995, Protein-primed RNA synthesis in vitro by the virion associated RNA polymerase of infectious pancreatic necrosis virus. Virology 208:19-25; Duncan, R., C. L. Mason, E. Nagy, J. A. Leong, and P. Dobos, 1991, Sequence analysis of infectious pancreatic necrosis virus genome segment B and its encoded VP1 protein: A putative RNA-de

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for generating nonpathogenic infectious pancreatic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for generating nonpathogenic infectious pancreatic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for generating nonpathogenic infectious pancreatic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2454613

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.